Molecular Partners announced Patrick Amstutz as CEO, detailing the career background of Martin Steegmaier, including his previous roles at Roche, MorphoSys, and Boehringer Ingelheim.
2 reports, 2 independent
Updated Oct 29
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Molecular Partners announced Patrick Amstutz as CEO, detailing the career background of Martin Steegmaier, including his previous roles at Roche, MorphoSys, and Boehringer Ingelheim.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Molecular Partners, led by Patrick Amstutz, announced a partnership with Novartis.1 source
Molecular Partners appoints Patrick Amstutz as CEO; details of Martin Steegmaier's career path are revealed.1 source
Keep exploring
The entities involved
-
Molecular Partners
biopharmaceutical company based in Zürich, Switzerland
Nothing else this week.
-
Patrick Amstutz
Nothing else this week.
-
Martin
Nothing else this week.
Coverage
Newest first; wire copies grouped- jobsnhire.com
- GlobeNewswireMolecular Partners appoints Martin Steegmaier as Chief Scientific Officer to drive discovery of next-gen DARPin therapeutics Extensive experience from senior oncology research roles at Roche, MorphoS